These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4023609)

  • 1. Biliary secretion of bilirubin and lipids in chronic cholestatic liver disease.
    Kesäniemi YA; Miettinen TA
    Scand J Gastroenterol; 1985 May; 20(4):433-8. PubMed ID: 4023609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary lipid secretion in chronic cholestatic liver disease.
    Kesäniemi YA; Salaspuro MP; Vuoristo M; Miettinen TA
    Gut; 1982 Nov; 23(11):931-8. PubMed ID: 7129204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physico-chemical factors predisposing to pigment gallstone formation in liver cirrhosis.
    Alvaro D; Angelico M; Gandin C; Ginanni Corradini S; Capocaccia L
    J Hepatol; 1990 Mar; 10(2):228-34. PubMed ID: 2332595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary lipid metabolism in children with chronic intrahepatic cholestasis.
    Becker M; von Bergmann K; Rotthauwe HW; Leiss O
    Eur J Pediatr; 1984 Nov; 143(1):35-40. PubMed ID: 6510428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving concepts in the pathophysiology of biliary lipid secretion.
    Carrella M; Roda E
    Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):643-8. PubMed ID: 10604109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneously diabetic biobreeding rats and impairment of bile acid-independent bile flow and increased biliary bilirubin, calcium and lipid secretion.
    González J; Fevery J
    Hepatology; 1992 Aug; 16(2):426-32. PubMed ID: 1639353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
    Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
    Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary excretion in Sprague-Dawley and Gunn rats during manganese-bilirubin-induced cholestasis.
    Ayotte P; Plaa GL
    Hepatology; 1988; 8(5):1069-78. PubMed ID: 3417227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A distinctive pattern of serum bile acid and bilirubin concentrations in benign recurrent intrahepatic cholestasis.
    Summerfield JA; Kirk AP; Chitranukroh A; Billing BH
    Hepatogastroenterology; 1981 Jun; 28(3):139-42. PubMed ID: 7250892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease.
    Brink MA; Slors JF; Keulemans YC; Mok KS; De Waart DR; Carey MC; Groen AK; Tytgat GN
    Gastroenterology; 1999 Jun; 116(6):1420-7. PubMed ID: 10348826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.
    Lirussi F; Okolicsanyi L
    Ital J Gastroenterol; 1992 Jan; 24(1):31-5. PubMed ID: 1571577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathophysiology of cholestasis with special reference to primary biliary cirrhosis.
    Jansen PL
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):571-83. PubMed ID: 10976015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of gallbladder bile lithogenicity in patients with primary biliary cirrhosis.
    Fracchia M; Jazrawi RP; Galatola G
    Ital J Gastroenterol; 1996 Jun; 28(5):255-60. PubMed ID: 8842843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
    Trauner M; Fickert P; Halilbasic E; Moustafa T
    Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanisms of bile formation and cholestatic diseases].
    Poupon R
    Bull Acad Natl Med; 2003; 187(7):1261-74; discussion 1274-6. PubMed ID: 15146603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of obesity and caloric intake on biliary lipid metabolism in man.
    Bennion LJ; Grundy SM
    J Clin Invest; 1975 Oct; 56(4):996-1011. PubMed ID: 1159099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phenobarbital on biliary lipid metabolism in children with chronic intrahepatic cholestasis.
    Becker M; von Bergmann K; Rotthauwe HW; Leiss O
    Eur J Pediatr; 1984 Nov; 143(1):41-4. PubMed ID: 6510429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary bacterial infection decreased the secretion of bile acids and bilirubin into bile.
    Nishida T; Nakahara M; Nakao K; Matsuda H
    Am J Surg; 1999 Jan; 177(1):38-41. PubMed ID: 10037306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different doses of ursodeoxycholic acid in chronic liver disease.
    Podda M; Ghezzi C; Battezzati PM; Bertolini E; Crosignani A; Petroni ML; Zuin M
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):59S-65S. PubMed ID: 2598769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in lipids, bilirubin and metal elements in the gallbladder bile in patients with cirrhosis of the liver].
    Zhu JF; Shan LC; Chen WH
    Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):767-9. PubMed ID: 7600868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.